|
(OTCBB:
NAWL)
NatureWell is publicly traded and engaged in the research and development of
unique proprietary healthcare products intended for a variety of conditions.
Currently the Company’s primary focus is on the distribution and sale of its
migraine medication, MigraSpray®. This homeopathic over-the-counter drug is
used for the treatment and prevention of migraine headaches. The Company
intends to exclusively market MigraSpray to healthcare professionals and
directly to consumers.
NatureWell believes that a strong need exists for a safe and effective
over-the-counter medications for the treatment of a number of conditions.
MigraSpray, the Company’s first product will be positioned as a comprehensive
first-line of defense for relieving and preventing migraine headaches. This
distribution is designed to build a platform that can be used in the future to
launch products in the Company's pipeline. The Company plans to market
MigraSpray to healthcare providers using in-house and outside sales
representatives and distributors and plans to also continue selling MigraSpray
via the Internet and other direct-to-consumer sales.
JAMES R. ARABIA – Chairman, CEO and President
Mr. Arabia assumed the role of Chairman of the Board of Directors in January
2002, and became President and Chief Executive Officer of the Company during
September 2001. From February 1997 through June 2000, Mr. Arabia served as
Chairman, Chief Executive Officer and President of ICH Corporation, an American
Stock Exchange listed company. During Mr. Arabia's tenure, ICH grew from a
non-operational company to becoming the parent company of various subsidiaries
that owned and operated 265 fast food and family dining restaurants, generating
approximately $245 million in revenues and employing approximately 7,800
people. From 1982 through 1997, Mr. Arabia provided financial advisory and
investment banking services to a variety of private clients.
|